|
Savlevich E.L., Markus P.V., Angotoeva I.B., Kirichenko I.M., Bessonov K.K.
Causes of pain syndrome in case of oropharynx inflammatory diseases
|
№6 / 2024
|
|
Golendyaeva P.I., Livzan M.A., Gaus O.V., Korennova O.Yu., Mozgovoy S.I.
Gastropathy associated with antiplatelet and anticoagulant therapy: prevalence and risk factors
|
№8 / 2023
|
|
Dronova Yu.M., Mubarakshina O.A., Chernov S.Yu.
Non-steroid anti-inflammatory drugs in musculoskeletal pain syndrome therapy: Aspects of their effective and safe use
|
№5 / 2023
|
|
Bolieva L.Z., Adasheva T.V., Daurova M.D.
Coxibs cardiovascular safety
|
№4 / 2023
|
|
Rebrov A.P., Tyapkina M.A., Ordyakova A.A., Yupatov V.D., Kosheleva N.A., Basov I.V.
Patients with cardiovascular diseases and NSAIDs intake: Is there a real problem today?
|
№4 / 2023
|
|
|
№3 (приложение) / 2023
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 2: management of patients with cardiovascular, gastrointestinal, renal, liver diseases, pregnancy, also having anticoagulant therapy and patients in perioperative period
|
№2 / 2023
|
|
Kudina E.V. Samkova I.A.
Anti-inflammatory therapy of joint syndrome in an outpatient practitioner
|
№1 / 2023
|
|
Lyalina V.V., Skripnichenko E.A., Borisovskaya S.V., Obyedkov R.N., Nikitin I.G.
Peculiarities of acute gouty arthritis treatment in patients with concomitant pathology. Part 1: main limitations and adverse effects of medicamentous therapy
|
№1 / 2023
|
|
Trofimov E.A., Mazurov V.I., Bashkinov R.A., Trofimova A.S., Gaydukova I.Z.
Comparative analysis of efficacy and safety of different medicines containing celecoxib in patients with knee osteoarthritis
|
№1 / 2023
|
|
Viktorova I.A., Ivanova D.S., Konshu N.V.
Prospective two-year observation of patients with the syndrome of joint hypermobility
|
№7 / 2019
|
|
Lazebnik L.B., Belova G.V.
Practical application of «Systematizing classification of the mucous digestive tract membrane multifocal damages by NSAIDs and antithrombotic medicines» together with the other RSMSIM clinical guidelines for optimization of decision-making in complex clinical situations
|
№6 / 2019
|
Русский
